Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INTUITIVE SURGICAL INC Director's Dealing 2022

Sep 9, 2022

29809_dirs_2022-09-09_808914ab-24bc-4290-b8f7-82128380b550.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2022-09-08

Reporting Person: Johnson Amal M (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-09-08 Common Stock M 6375 $53.7556 Acquired 17599 Direct
2022-09-08 Common Stock S 6375 $210.7583 Disposed 11224 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-09-08 Non-Qualified Stock Option (right to buy) $53.7556 M 6375 Disposed 2023-04-25 Common Stock (6375) Direct

Footnotes

F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 26, 2023.

F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $208.23 to $213.36 as follows: 1,665 shares sold at $208.23 - $209.08; 1,300 shares sold at $209.25 - $210.25; 715 shares sold at $210.46 - $210.95; 1,264 shares sold at $211.74 - $212.71; and 1431 shares sold at $212.75 - $213.36. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F3: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.